← Evidence map

ReviewmAbs2015

Clinical considerations for the development of biosimilars in oncology.

Mark A Socinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25621390